According to Spero Therapeutics's latest financial reports the company's current earnings (TTM) are โฌ15.82 M. In 2023 the company made an earning of โฌ21.17 M an increase over its 2022 earnings that were of -โฌ39.54 M.The earnings displayed on this page is the company's Pretax Income.